Nick Lenard
InvestorAnalyst, Public Equity at Sofinnova Ventures
About
Nick Lenard joined Sofinnova BioEquities as an Analyst in 2025, where he works on public investments in biotechnology and pharmaceutical companies globally. He previously spent over four years on the sell side covering SMid and Large Cap Biotechnology, most recently as a Vice President at J.P. Morgan. He holds an M.A. in Biotechnology from Columbia University and a B.A. in Chemistry from Kenyon College.
Invests in
Biotech
Colleagues at Sofinnova Ventures
Alex Chan
Controller, Private Equity at Sofinnova Ventures
Alex Dulnev
IT Manager at Sofinnova Ventures
Amanda Phillips
Executive Assistant at Sofinnova Ventures
Anastasia Voevodin
Analyst, Public Equity at Sofinnova Ventures
Aneal Tenjarla
Partner, Associate Portfolio Manager, Public Equity at Sofinnova Ventures
Calvin Sternick
Analyst, Public Equity at Sofinnova Ventures
Chris Carpenter
Executive Partner, Private Equity at Sofinnova Ventures
David Kabakoff
Executive Partner, Private Equity at Sofinnova Ventures
Frequently asked questions
- Who is Nick Lenard?
- Nick Lenard joined Sofinnova BioEquities as an Analyst in 2025, where he works on public investments in biotechnology and pharmaceutical companies globally. He previously spent over four years on the sell side covering SMid and Large Cap Biotechnology, most recently as a Vice President at J.P. Morgan. He holds an M.A. in Biotechnology from Columbia University and a B.A. in Chemistry from Kenyon College.
- Where does Nick Lenard work?
- Nick Lenard is Analyst, Public Equity at Sofinnova Ventures.
- What does Nick Lenard invest in?
- Nick Lenard invests in Biotech.